文献速递重症综合管理与镇静镇痛消化、代谢与肾脏急症

连续性肾脏替代治疗中枸橼酸抗凝致心律失常的原因分析

[Analysis of the causes of arrhythmia induced by citrate anticoagulation in continuous renal replacement therapy].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2021-01-01
一句话结论回顾性队列显示,接受局部枸橼酸抗凝的连续性肾脏替代治疗患者心律失常发生率较低(13.95%),发生心律失常时总钙升高、血镁降低,可能与枸橼酸蓄积及钙、磷、镁等电解质紊乱有关。

该研究为回顾性队列研究,纳入2020年1月1日至2020年10月31日在天津市第三中心医院重症监护病房接受局部枸橼酸抗凝连续性肾脏替代治疗的患者86例,按是否发生心律失常分为心律失常组(12例,13.95%)与非心律失常组(74例,86.05%)。心律失常平均发生时间为(44.00±16.82)小时。心律失常发生时与治疗前相比,心电图ST段无显著变化,总钙显著升高(2.48±0.40 vs. 2.13±0.35 mmol/L,P<0.05),血镁显著降低(0.73±0.20 vs. 0.95±0.25 mmol/L,P<0.05),血清游离钙、血磷、血钾、pH值及HCO3-无显著差异。随时间推移两组总钙水平均升高,治疗48小时与治疗前比较均有统计学差异;心律失常组治疗72小时总钙显著高于非心律失常组(2.69±0.35 vs. 2.45±0.23 mmol/L,P<0.05)。结论提示接受局部枸橼酸抗凝连续性肾脏替代治疗的患者心律失常发生率较低,原因可能与枸橼酸蓄积及钙、磷、镁等电解质紊乱有关。

要点

  • 86例接受局部枸橼酸抗凝连续性肾脏替代治疗的患者中,12例(13.95%)发生心律失常,平均发生时间为(44.00±16.82)小时。
  • 心律失常发生时与治疗前相比,总钙显著升高(2.48±0.40 vs. 2.13±0.35 mmol/L,P<0.05),血镁显著降低(0.73±0.20 vs. 0.95±0.25 mmol/L,P<0.05)。
  • 心律失常发生时与治疗前相比,血清游离钙、血磷、血钾、pH值及HCO3-无显著差异,心电图ST段无显著变化。
  • 治疗72小时心律失常组总钙显著高于非心律失常组(2.69±0.35 vs. 2.45±0.23 mmol/L,P<0.05),但血清游离钙、磷、镁、钾、pH值及HCO3-两组间无显著差异。
  • 随时间推移两组总钙均升高、血磷和血镁均降低;心律失常组血钾降低,非心律失常组血钾无显著变化。

适用人群与场景

  • 2020年1月1日至2020年10月31日在天津市第三中心医院重症监护病房接受局部枸橼酸抗凝连续性肾脏替代治疗的患者86例。
  • 按是否发生心律失常分为心律失常组(12例)与非心律失常组(74例)。

研究设计与关键结果

  • 研究类型:回顾性队列研究;样本量86例;人群:重症监护病房接受局部枸橼酸抗凝连续性肾脏替代治疗的患者。
  • 心律失常发生率:12例(13.95%)发生心律失常,其余74例(86.05%)未发生心律失常。
  • 心律失常平均发生时间为(44.00±16.82)小时。
  • 心律失常发生时与治疗前比较:总钙显著升高(2.48±0.40 vs. 2.13±0.35 mmol/L,P<0.05),血镁显著降低(0.73±0.20 vs. 0.95±0.25 mmol/L,P<0.05);血清游离钙、血磷、血钾、pH值、HCO3-及心电图ST段无显著差异。
  • 随时间变化:两组总钙均升高,治疗48小时与治疗前比较均有统计学差异(心律失常组2.48±0.33 vs. 2.13±0.35 mmol/L,非心律失常组2.30±0.22 vs. 2.15±0.48 mmol/L,均P<0.05);两组血清游离钙、pH值及HCO3-线性变化趋势不明显;两组血磷和血镁均降低;心律失常组血钾降低,非心律失常组血钾无显著变化。
  • 治疗72小时心律失常组总钙显著高于非心律失常组(2.69±0.35 vs. 2.45±0.23 mmol/L,P<0.05);两组血清游离钙、磷、镁、钾、pH值及HCO3-无显著差异。

证据类型、等级与局限

  • 证据类型:回顾性队列研究。
  • 结论:接受局部枸橼酸抗凝连续性肾脏替代治疗的患者心律失常发生率较低,原因可能与枸橼酸蓄积及钙、磷、镁等电解质紊乱有关。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 接受局部枸橼酸抗凝连续性肾脏替代治疗的患者心律失常发生率较低(12/86,13.95%),心律失常平均发生于治疗(44.00±16.82)小时。
  • 心律失常发生时总钙较治疗前升高、血镁较治疗前降低,而血清游离钙、血磷、血钾、pH值及HCO3-无显著变化,提示总钙与血镁的监测可能有助于识别心律失常风险。
  • 治疗48小时两组总钙均较治疗前升高,治疗72小时心律失常组总钙高于非心律失常组,提示随时间推移总钙升高可能与心律失常发生相关;作者认为原因可能与枸橼酸蓄积及钙、磷、镁等电解质紊乱有关。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To analyze the possible causes of arrhythmia in patients receiving continuous renal replacement therapy (CRRT) with regional citrate anticoagulation (RCA).

METHODS: A retrospective cohort study was conducted. All patients underwent RCA-CRRT treatment from January 1, 2020 to October 31, 2020 in the intensive care unit (ICU) of Tianjin Third Central Hospital were enrolled. The patients were divided into arrhythmia group and non-arrhythmia group according to whether arrhythmia occurred. The gender, age, acute physiology and chronic health evaluation II (APACHE II) score, catheterization site, underlying diseases, electrocardiogram (ECG), electrolytes [total calcium, serum free calcium (iCa2+), phosphorus, magnesium, potassium] and blood gas analysis (pH value, HCO3-) of patients in the two groups were recorded. The changes of ECG were observed, the differences in electrolyte and blood gas analysis indexes between the two groups of patients at different time points (before CRRT, 24, 48, 72 hours after CRRT, and when arrhythmia occurred) were compared.

RESULTS: A total of 86 RCA-CRRT patients were enrolled, of which 12 cases (13.95%) had arrhythmia, and the remaining 74 cases (86.05%) had no arrhythmia. The average time for the occurrence of arrhythmia in the 12 patients was (44.00±16.82) hours. There was no significant ST-segment change in the ECG when the arrhythmia occurred compared with that before CRRT, the total calcium level was significantly higher than that before CRRT (mmol/L: 2.48±0.40 vs. 2.13±0.35, P < 0.05), the blood magnesium level was significantly lower than that before CRRT (mmol/L: 0.73±0.20 vs. 0.95±0.25, P < 0.05). There was no significant difference in iCa2+, blood phosphorus, blood potassium, pH value and HCO3- between before CRRT and when arrhythmia occurred. Over time, the total calcium levels in the two groups increased, and there was a statistical difference between the 48 hours after CRRT and before CRRT (mmol/L: 2.48±0.33 vs. 2.13±0.35 in the arrhythmia group, and 2.30±0.22 vs. 2.15±0.48 in non-arrhythmia group, both P < 0.05). The linear change trend of iCa2+, pH value and HCO3- was not obvious in the two groups. The blood phosphorus and blood magnesium levels in the two groups decreased. The blood potassium in the arrhythmia group decreased, however, the blood potassium level in non-arrhythmia group did not change significantly. The total calcium level in the arrhythmia group was significantly higher than that in the non-arrhythmia group at 72 hours after CRRT (mmol/L: 2.69±0.35 vs. 2.45±0.23, P < 0.05); however, there was no significant difference in serum iCa2+, phosphorus, magnesium, potassium, pH value and HCO3- between the two groups.

CONCLUSIONS: Patients receiving RCA-CRRT were less likely to develop arrhythmia, the causes may be related to the accumulation of citric acid and electrolyte disturbances such as calcium, phosphorus, and magnesium.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Gao X, Feng Q, Xu L, et al. [Analysis of the causes of arrhythmia induced by citrate anticoagulation in continuous renal replacement therapy]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2021. PMID: 34296699. doi:10.3760/cma.j.cn121430-20210203-00197

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。